Comparative Pharmacology
Head-to-head clinical analysis: BENTYL versus DICYCLOMINE HYDROCHLORIDE PRESERVATIVE FREE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BENTYL versus DICYCLOMINE HYDROCHLORIDE PRESERVATIVE FREE.
BENTYL vs DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE)
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dicyclomine is a muscarinic acetylcholine receptor antagonist that blocks the action of acetylcholine at postganglionic parasympathetic effector sites, reducing gastrointestinal smooth muscle spasms and hypermotility.
Competitive antagonist of muscarinic acetylcholine receptors (M1, M2, M3) in the gastrointestinal tract, producing antispasmodic effects by reducing smooth muscle contractions.
20 mg orally four times daily; may increase to 40 mg four times daily if tolerated. Immediate-release: 20 mg orally every 6 hours. Extended-release: 20 mg orally twice daily.
20 mg intramuscularly every 4-6 hours.
None Documented
None Documented
1.9 to 3 hours (terminal elimination half-life); clinical context: short half-life supports multiple daily dosing for spasm relief.
5-8 hours; may be prolonged in elderly or patients with hepatic impairment
Primarily renal (approximately 60% as unchanged drug and metabolites) and fecal (about 40% via biliary elimination).
Renal (approximately 50-80% as unchanged drug and metabolites), biliary/fecal (minor, <10%)
Category C
Category A/B
Anticholinergic
Anticholinergic